xiv jmt - how i select the best agent to treat patients with relapsed myeloma dr adriana rossi
Published 7 years ago • 51 plays • Length 21:39Download video MP4
Download video MP3
Similar videos
-
6:44
treatment for multiple myeloma
-
24:19
ravi vij, in discussion with dr. adriana rossi md, on isatuximab for transplant ineligible patients
-
1:56
treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
-
4:33
standard treatment options for multiple myeloma
-
2:29:01
new strategies for multiple myeloma care: next steps for the future
-
1:10:32
newly diagnosed multiple myeloma | diagnosis, initial treatment | asct, maintenance therapy, goals
-
1:27:20
understanding my treatment options: multiple myeloma
-
43:30
long lecture on methionine restriction to slow aging & help prevent cancer = fabian strategy
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
4:02
understanding multiple myeloma
-
1:56
t cell therapies | adriana rossi, md | tandem 2022
-
1:52
available cd38 antibodies for multiple myeloma
-
2:33
an update on antibody-based treatment approaches in multiple myeloma
-
1:17
changes in myeloma treatment following implementation of the imwg criteria
-
4:51
risk stratification & treatment of multiple myeloma precursor conditions
-
1:18
how next-generation sequencing will change the treatment of multiple myeloma
-
9:13
treatment selection and sequencing for multiple myeloma
-
1:59
factors to consider when choosing between cilta-cel and ide-cel for r/r multiple myeloma
-
4:56
multiple myeloma - difficult to diagnose; powerful new treatment options
-
1:04
the changing role of autosct in the treatment of multiple myeloma in the era of novel agents
-
2:26
factors to consider when selecting myeloma patients for antibody therapy
-
0:52
mrd for multiple myeloma: is it ready for prime-time?